Optimizing Pharmaceutical API Processes
Explore how our systemic approach to API processes yielded close to 100% reduction of API content variation and a reduction of batch scrap rate from 40% to 10%.
Bringing a Combination Medical Product to market is complex. With dual regulatory frameworks, cross-functional teams, and complex supplier networks, the risks are high, and delays can cost you. That’s why Emendo streamlines and delivers your drug combination product from strategy to launch - faster, smarter, and fully compliant.
Emendo bridges the gap between pharmaceutical development and medical device engineering. In particular, we specialize in aligning regulatory strategy, technical development, and operations. As a result, this creates a unified, agile process that accelerates time to market for combination product medical products.
Our R&D consultants will support you at every step. Whether you’re developing a combination medical product for chronic disease management or launching an innovative delivery platform. At Emendo we offer practical, hands-on consulting that drives real outcomes.

Finding the right device manufacturer or contract manufacturing organization (CMO) is a critical step. To facilitate this, Emendo leverages its supplier network and leads the RFx process – from defining requirements and evaluating proposals to contract negotiations.
By following this structured approach, we prevent costly re-design. We also ensure supplier transparency, alignment with your technical needs, and control over product manufacturing timelines and costs.
Our consultants support you in defining the right technical and user requirements early in the development process. Emendo helps map out intended use indications or effects and incorporate human factors engineering.
Additionally, we align product specifications with the constituent parts of your pharmaceutical formulation. Whether you’re working with prefilled syringes, autoinjectors, or other delivery devices. We keep product functionality and patient usability at the core of the design.
We provide support in building robust design history files and writing documentation that complies with product standards, such as ISO 11608 and ISO 11040. The team designs and documents the necessary design verification and stability studies to justify shelf-life. Statistical subject matter expertise is also offered to justify sample sizes and analyze test results.
Thanks to our product and methodology knowledge (ISO 14971), we also conduct and give technical inputs to risk assessments throughout the design control process.
Our regulatory experts help you navigate the complex frameworks that govern drug-device combination products. To ensure compliance, regulatory pathways are aligned with the primary mode of action, guided by internationally recognized guidelines (e.g., EU MDR; FDA CFR; other XX ), and to receive approval according to the specific markets.
Furthermore, by defining the correct classification – whether a single entity or cross-labeled combination product – early on, we minimize risk and prevent late-stage surprises.
From early project planning to execution and lifecycle support, we act as an extension of your team. More specifically, our team manages complex dependencies across Pharma and MedTech and coordinates third-party vendors.
As a result, this ensures your combination product project stays on track, on budget, and fully compliant.
Combination products are critical in delivering safe, effective treatment in today’s healthcare landscape. Their user-friendly design and convenience support self-administration, improve patient adherence, and reduce the burden on healthcare systems. By simplifying the injection process and enhancing the overall patient experience, these products contribute significantly to the effective management of chronic and acute conditions requiring biologic therapies. As a result, drug device combination products such as prefilled drug delivery systems are increasingly in demand. Notably, the global syringe market share is projected to grow from US$ 6.69 billion in 2022 to US$ 15.0 billion by 2030.
Combining drug and device elements brings added complexity. Understanding the regulatory pathway, identifying and executing the necessary studies, and managing the complex CMO ecosystem can stall projects if not handled correctly.
To navigate this complexity successfully, Pharma teams must integrate device and medical product thinking from the earliest stages – starting with formulation and continuing through packaging and delivery. By partnering with experienced R&D consultants, you ensure the right expertise is in place to meet regulatory requirements, streamline development, and bring combination products to market with confidence.

CASE SPOTLIGHT
Pharma teams often face a critical challenge when bringing combination products to market: bridging the gap between pharmaceutical formulation and device engineering. In this case, a leading pharmaceutical company sought additional expertise in medical device development. Consequently, they partnered with our team.
Initially, we bridged the knowledge gap by conducting workshops to educate internal teams on device development methodologies, risk assessment, and design requirements. As the project evolved, we expanded our role to lead:
These actions led to measurable cost savings and a smoother regulatory journey.

Keen to learn more?
Bringing a combination product to market takes more than technical know-how – it requires a clear regulatory path and integrated development strategy. Whether you’re launching your first combination product or scaling an existing platform, our team is here to help you move forward with confidence.
Reach out to Britt Dam Raabyto discuss how we can support your combination product development journey.

Explore how our systemic approach to API processes yielded close to 100% reduction of API content variation and a reduction of batch scrap rate from 40% to 10%.
Discover how we achived cost savings while ensuring compliance with regulatory standards when we supported a client in the development of a user-friendly injection device.
Discover how we implemented a new analytical test method to ensure the quality and safe use of a novel drug substance for clinical trial material.
Our people at Research and Development are the true driving force behind our success. We have assembled an incredible team of experts who come from diverse backgrounds, but they all share a common thread: a genuine passion for their industry and an unwavering commitment to exceeding our clients’ expectations.
HAVE A QUESTION